Finance

Lists
ANRO:NYSE
Alto Neuroscience Inc
24,37 $
+1,41%
(+0,34) 1D
9 հոկ, 16:00:04 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANRO...
Open
24,00 $
High
25,11 $
Low
23,81 $
Mkt. cap
956,33 մլն
Avg. vol.
566,23 հզր
Volume
0,00
52-wk high
37,48 $
52-wk low
5,22 $
EPS
-2,44 $
Shares outstanding
39,24 մլն
No. of employees
68
Open
24,00 $
High
25,11 $
Low
23,81 $
Mkt. cap
956,33 մլն
Avg. vol.
566,23 հզր
Volume
0,00
52-wk high
37,48 $
52-wk low
5,22 $
EPS
-2,44 $
Shares outstanding
39,24 մլն
No. of employees
68
News stories
From web sources and news partners
About Alto Neuroscience Inc
CEO-
Employees68
Founded2019
Headquarters-
Sector-
Websitealtoneuroscience.com
Analyst ratings
Based on 5 analysts giving stock ratings to ANRO in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ANRO in the last 3 months.
Highest
Current 24,37 $
55,00 $ (+125,69%)
Average
44,00 $ (+80,55%)
Lowest
37,00 $ (+51,83%)
Analyst
Recommendation
Action
Price target
Projected
Date
Myles Minter
William Blair
Buy
Reiterated
-
-
10/02/2026
Patrick Trucchio
H.C. Wainwright
Buy
Maintained
55,00 $
+125,7%
09/21/2026
Tazeen Ahmad
Bank of America Securities
Buy
Maintained
-
-
08/14/2026
Andrew Tsai
Jefferies
Buy
Maintained
40,00 $
+64,1%
08/13/2026
Thomas Shrader
BTIG
Buy
Reiterated
37,00 $
+51,8%
08/13/2026
Justin Walsh
JonesTrading
Buy
Reiterated
44,00 $
+80,5%
06/26/2026
Brian Skorney
Robert W. Baird
Buy
Maintained
36,00 $
+47,7%
05/18/2026
Laura Chico
Wedbush
Hold
Maintained
24,00 $
-1,5%
05/14/2026
Ritu Baral
TD Cowen
Buy
Maintained
-
-
05/13/2026
Keay Nakae
Chardan Capital
Buy
Maintained
30,00 $
+23,1%
04/21/2026
Paul Matteis
Stifel Nicolaus
Buy
Maintained
33,00 $
+35,4%
04/02/2026
Last report
12 օգս, 2026 թ.
Fiscal period
Q2 2026
-0,65 $ / -0,77 $
+15,95%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
10,52 մլն
12,00 մլն
20,29 մլն
22,11 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,43 մլն
5,06 մլն
6,84 մլն
7,02 մլն
Operating expense
14,95 մլն
17,06 մլն
27,14 մլն
29,13 մլն
Total operating expenses
14,95 մլն
17,06 մլն
27,14 մլն
29,13 մլն
Operating income
-14,95 մլն
-17,06 մլն
-27,14 մլն
-29,13 մլն
Other non operating income
-112,00 հզր
-113,00 հզր
-115,00 հզր
-130,00 հզր
EBT including unusual items
-14,18 մլն
-16,18 մլն
-26,24 մլն
-27,64 մլն
EBT excluding unusual items
-14,18 մլն
-16,18 մլն
-26,24 մլն
-27,64 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14,18 մլն
-16,18 մլն
-26,24 մլն
-27,64 մլն
Net profit margin
-
-
-
-
Earnings per share
-0,52
-0,45
-0,80
-0,65
Interest and investment income
1,53 մլն
1,56 մլն
1,56 մլն
2,11 մլն
Interest expense
-650,00 հզր
-575,00 հզր
-545,00 հզր
-491,00 հզր
Net interest expenses
882,00 հզր
986,00 հզր
1,02 մլն
1,62 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-14,79 մլն
-16,90 մլն
-26,95 մլն
-28,94 մլն
Gain or loss from assets sale
114,00 հզր
-
9,00 հզր
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps